OnBioVC

Ember Therapeutics, Inc.: Series A $34.1M

arubenstein — Sat, 04 Feb 2012 04:13:29 +0000

Ember Therapeutics (Boston, MA) a preclinical-stage pharmaceutical company focused on diabetes, obesity and metabolic diseases closed a $34.1M Series A financing. Participants include Third Rock Ventures.

HealthTap, Inc.: Series A $11.5M

arubenstein — Fri, 03 Feb 2012 07:00:56 +0000

HealthTap (Palo Alto, CA) a web-based company focused on applications for the exchange of health information between patients and physicians, closed a $11.5M Series A financing. Participants include Mayfield Fund, Mohr Davidow Ventures and Innovation Endeavors.

C8 MediSensors, Inc.: Series E $24M

arubenstein — Fri, 03 Feb 2012 07:00:54 +0000

C8 MediSensors (San Jose, CA) a clinical-stage medical device company focused on non-invasive continuous glucose monitors, closed a $24M Series E financing. Participants have included GE Healthymagination Fund.

CircuLite, Inc.: Series D $30M

arubenstein — Fri, 03 Feb 2012 07:00:39 +0000

CircuLite (Saddle Brook, NJ) a clinical-stage medical device company focused on minimally invasive implantable devices for chronic heart failure, closed a $30M Series D financing. Participants include Forbion Capital Partners and MacAndrews & Forbes Holdings.

TopiVert, Ltd.: Series A $12.5M

arubenstein — Fri, 03 Feb 2012 07:00:35 +0000

TopiVert (United Kingdom) a development-stage pharmaceutical company focused on topical medicines for inflammatory diseases of the eye and gut, closed a $12.5M Series A financing. Participants include Imperial Innovations Group and SV Life Sciences.

CeNeRx BioPharma, Inc.: Series D $4.6M

arubenstein — Fri, 03 Feb 2012 07:00:19 +0000

CeNeRx (Cary, NC) a clinical-stage biopharmaceutical company focused on diseases of the central nervous system, depression and anxiety, closed a $4.6M Series D financing. Participants include Aisling Capital, L Capital Partners, Perseus Soros Biopharmaceutical Fund, Omega Funds and Pappas Ventures.

MedLumics: Series A $4.7M

arubenstein — Fri, 03 Feb 2012 07:00:15 +0000

MedLumics (Spain) a development-stage diagnostic device company focused on optical coherence tomography imaging for ophthalmology and intravascular imaging in cardiology, dermatology and dentistry, closed a $3.25M Series A financing. Participants include Ysios Capital Partners and Caixa Capital.

Cervilenz, Inc.: Series A $8.4M

arubenstein — Thu, 02 Feb 2012 07:00:59 +0000

Cervilenz (Chagrin Falls, OH) a development-stage device company focused on the a disposable to identify and manage pregnant women at high risk for preterm birth, closed an $8.35M Series A financing. Participants include Arboretum Ventures and Chrysalis Ventures.

Sensors for Medicine and Science, Inc.: Series D $54.1M

arubenstein — Thu, 02 Feb 2012 07:00:37 +0000

Sensors for Medicine and Science (Germantown, MD) a commercial-stage device company focused on implantable, long- term continuous glucose monitoring, closed a $54.1M million in Series D financing. Participants include Delphi Ventures, New Enterprise Associates, HealthCare Ventures, Anthem Capital and Greenspring Associates.

Pivot Medical, Inc.: Series C $32M

arubenstein — Thu, 02 Feb 2012 07:00:30 +0000

Pivot Medical (Sunnyvale, CA) a clinical-stage device company focused on minimally invasive hip restoration technologies, closed a $32M Series C financing. Participants include Adams Street Partners, Delphi Ventures, Montreux Equity Partners and Ivy Capital Partners.

Leonardo Biosystems, Inc.: Series A $1.25M

arubenstein — Thu, 02 Feb 2012 07:00:26 +0000

Leonardo Biosystems (Houston, TX) a development-stage biopharmaceutical company focused on drug delivery technology, closed a $1.25M Series A financing, bringing the total round to $2.5M. Participants include Texas Emerging Technology Fund.

Tangent Medical Technologies, Inc.: Series A $4.5M

arubenstein — Thu, 02 Feb 2012 07:00:20 +0000

Tangent Medical Technologies (Ann Arbor, MI) a development-stage medical device company focused on peripheral intravenous delivery systems, closed a $4.5M Series A financing. Participants include Arboretum Ventures, Flagship Ventures and Osage Ventures.

Inova Labs, Inc.: Series B $17.5M

arubenstein — Thu, 02 Feb 2012 07:00:13 +0000

Inova Labs (Austin, TX) a medical device company focused on the development, manufacturing, and worldwide distribution of medical devices used to treat Chronic Obstructive Pulmonary Disease, closed a $17.5 million in Series B financing. Participants include Latterell Venture Partners, Gilde Healthcare Partners and Three Arch Partners.